Skip to main content

Table 4 Summary of European studies regarding the prevalence of HPV in women with cytological abnormalities

From: HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities

Authors (Year)

Citation

N (Country)

Method of Analysis

HPV+ (%)

 Bonde et al. (2014)

[7]

5068 (Denmark)

CLART

88.9%

 Capra et al. (2008)

[19]

970 (Italy)

Nested PCR/sequencing INNO-LiPA

37.7%

 Delgado et al. (2012)

[20]

106 (Spain)

Linear Array

69.8%

 Meloni et al. (2014)

[21]

650 (Italy)

INNO-LiPA

52.6%

 Monsonego et al. (2008)

[22]

575 (France)

Linear Array

Hybrid Capture II

88.1%

 Panotopoulou et al. (2007)

[23]

997 (Greece)

PCR/sequencing

75.1%

 Rassu et al. (2005)

[24]

1335 (Italy)

PCR-RFLP

35.3%

 Simanaviciene et al. (2015)

[25]

547 (Lithuania)

PCR

67.6%

 Spinillo et al. (2009)

[26]

1218 (Italy)

INNO-LiPA

69.9%

 Yapijakis et al. (2008)

[27]

263 (Greece)

PCR-RFLP

81.7%